MSI2 and gastric cancer: It boosts MSI2 levels by blocking its degradation through ubiquitin, which in turn stabilizes c-Myc mRNA in an m6A-dependent way, helps prevent apoptosis, promotes stem cell traits, and boosts resistance to cisplatin in gastric cancer.